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Abstract
This paper describes the use of magnetic levitation (MagLev) to measure the association of
proteins and ligands. The method starts with diamagnetic gel beads that are functionalized
covalently with small molecules (putative ligands). Binding of protein to the ligands within the
bead causes a change in the density of the bead. When these beads are suspended in a
paramagnetic aqueous buffer and placed between the poles of two NbFeB magnets with like poles
facing, the changes in the density of the bead on binding of protein result in changes in the
levitation height of the bead that can be used to quantify the amount of protein bound. This paper
uses a reaction-diffusion model to examine the physical principles that determine the values of rate
and equilibrium constants measured by this system, using the well-defined model system of
carbonic anhydrase and aryl sulfonamides. By tuning the experimental protocol, the method is
capable of quantifying either the concentration of protein in a solution, or the binding affinities of
a protein to several resin-bound small molecules simultaneously. Since this method requires no
electricity and only a single piece of inexpensive equipment, it may find use in situations where
portability and low cost are important, such as in bioanalysis in resource-limited settings, point-of-
care diagnosis, veterinary medicine, and plant pathology. It still has several practical
disadvantages. Most notably, the method requires relatively long assay times and cannot be
applied to large proteins (> 70 kDa), including antibodies. The design and synthesis of beads with
improved characteristics (e.g., larger pore size) has the potential to resolve these problems.
INTRODUCTION
Bioassays that involve the binding of proteins to resin-bound small molecules are often used
to screen for inhibitors of proteins, and to identify cellular targets of bioactive small
molecules.1 On-bead binding assays are also used to determine the concentrations of specific
proteins in solutions.2 Current methods for on-bead binding assays often use fluorescent or
radioactive labels to quantify the binding of a receptor to its ligand.3 The installation and
measurement of these labels requires access to relatively expensive equipment and
materials. While these methods are very broadly useful, we believe that a low-cost, label-
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free alternative would be valuable for specific applications (for example, in point-of-care
diagnosis, especially in resource-limited environments).4
This article describes a method for measuring the association of proteins and ligands that
uses magnetic levitation (MagLev).5 The method employs porous diamagnetic beads that are
functionalized with covalently bound small molecules (putative ligands). We suspend these
diamagnetic beads in a paramagnetic aqueous solution, which is placed in a cuvette between
two permanent NdFeB magnets oriented with like poles facing each other (Figure 1). The
balance of gravitational and magnetic forces acting on the diamagnetic bead causes beads
within a range of densities to levitate; the density of the bead determines its equilibrium
position in the magnetic field.6 With an appropriate choice of bead, binding of protein to
ligands within the bead causes a change in the overall density of the bead, and results in a
change in the position at which it levitates.6a
This analytical method has the potential to be simple operationally. The underlying physical
chemistry is, however, more complicated: it requires partitioning of protein from solution
into the bead, diffusion of protein within the bead, and binding of the protein to the
immobilized ligands.7 To examine the fundamental principles that determine rates and
equilibrium constants as measured by this system, we have developed a model that enables
us to explore all of these characteristics. This model generates data in the form of density of
the bead as a function of time. We use this model to define the range of physical parameters
(e.g., concentration of protein, and dissociation constant of the protein-ligand complex) over
which we expect the assay to work. Detailed experimental work using a model system
supports the validity of this analysis and leads to predictions about how the system may be
improved.
The objective of this paper is to use physical-organic strategies to characterize a MagLev-
based analytical tool for detecting protein and analyzing protein-ligand interactions, rather
than to prove the generality and limits of this method in practical analysis. This study is thus
aimed at describing the fundamental processes by which the system operates, and building
an analytical model for it, with the goal of constructing the physical-chemical foundation for
future use in bioanalysis.
Our model system consists of poly[acryloylated O,O′-bis(2-aminopropyl) polyethylene
glycol] (PEGA) beads that are covalently labeled with known inhibitors of bovine carbonic
anhydrase (BCA; E.C. 4.2.1.1). We levitate these beads in solutions of BCA and monitor the
change in levitation height – and hence the change in density of the beads – over time, as
protein binds to the beads. We explain the observed kinetics using a reaction-diffusion
model, and validate this model by using it to explain the effects of varying several
experimental parameters (the concentration of protein, the concentration of immobilized
ligand, the protein-ligand binding constant, and the size of the beads) on the rate of protein
binding to the beads and the total amount of protein that binds to the beads.
This Maglev-based technique has six attributes that make it an attractive approach for
detecting protein-ligand binding events: (i) It is inexpensive (requiring only a capillary tube
or a cuvette filled with a paramagnetic solution, and two NdFeB magnets that cost ~$5 – 20
each). (ii) It is easy to use: the results can be visualized with the unaided eye. (iii) It is
sensitive: association or dissociation of pmoles of protein to or from an appropriate bead
results in an easily measurable change in its levitation height. (iv) It is quantitative: with the
correct orientation and separation of magnets, the amount of protein bound per bead
correlates linearly with the levitation height of the bead. (v) It can be multiplexed, and offers
a method for comparing binding constants of different ligands. (vi) It enables monitoring of
association and dissociation of proteins to and from beads in real time.
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The technique, however, has at least five characteristics that are either of uncertain value, or
are limitations: (i) The detection is carried out in non-physiological medium containing a
non-natural ion at moderate ionic strength (e.g., 300 mM chelated gadolinium, 6 mM
phosphate, pH 7.4).8 (ii) The assay requires at least one ligand (with Kd < 1 mM) that can be
attached covalently to the diamagnetic bead. (iii) The bead must be different in density from
the protein, so that the association of protein and ligand in the bead results in a change in the
average density of the bead. (iv) Mass transport (i.e., diffusion) of protein through the gel-
based bead is rate-limiting; measurement of protein-ligand on- and off-rates is, therefore, not
possible. (v) The effective pore size of the gel must be sufficiently large to allow protein in
solution to partition into the bead to a concentration that produces a perceptible change in
density.
Other techniques may also be used to detect protein binding to solid supports directly (e.g.,
quartz microbalances,9 cantilevers,10 force transduction,11 conductance modification,12
surface plasmon resonance,13 and other optical methods). These techniques, however,
certainly require electricity, and also often require sophisticated laboratory equipment. We
believe that using MagLev to monitor protein-ligand binding may, after further
development, find use in several situations requiring biochemical analysis, including: (i) in
the developing world, where access to electricity is not guaranteed, (ii) in point-of-care
settings, where a small and simple solution is desirable, and (iii) in applications for other in-
the-field settings where simplicity may be important (e.g., veterinary or plant pathology,
forensics, food quality, and other types of chemical analysis). MagLev-based binding assays
may also find use in protein-ligand binding assays in drug development and biochemistry,
where resin-bound small molecules are often used to identify inhibitors of proteins, or as a
research tool to aid in identifying the cellular targets of small molecules.
EXPERIMENTAL DESIGN
Design of the Device
We used a device we described previously; it consists of two commercial NdFeB magnets
(50 × 50 × 25 mm) positioned with like poles facing towards each other, 45 mm apart.6 In
this configuration of magnets, Eqn. 1 describes the vertical position of the levitating bead
(h), and indicates that the position correlates linearly with the density of the bead (ρbead).
(1)
In this equation, ρbead and ρm, (both kg·m−3) and χbead and χm (both unitless) are the
densities and the magnetic susceptibilities of the bead and the paramagnetic medium,
respectively; g is the acceleration due to gravity (m·s−2), μ0 is the magnetic permeability of
free space (N·A−2), d is the distance between the magnets (m), and B0 is the magnitude of
the magnetic field at the surface of the magnets (T).
Choice of the Paramagnetic Fluid
We chose to use buffered aqueous solutions of disodium gadolinium (III) diethyl-
lenetriaminepentaacetic acid (2Na+·Gd(DTPA)2−) as the medium for levitation. Gd(DTPA)
is a relatively low-cost ($μ/g), commercially available, water-soluble MRI contrast agent
with high magnetic susceptibility. The complex is non-denaturing to many proteins, and has
a stability constant of 1017.7 M−1 in aqueous solutions at pH 7.4.14,15 Adjusting the
concentration of the paramagnetic ion tunes the dynamic range and sensitivity of the assay.
Higher concentrations of the paramagnetic ion increase the dynamic range of the assay;
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lower concentrations increase the sensitivity.6c The absolute range can also be adjusted by
addition of a diamagnetic material with higher or lower density than the solution (e.g.,
sucrose or ethanol, respectively).6c
The experiments described in this paper can be conveniently performed in 300-mM
solutions of Gd(DTPA) in phosphate-buffered saline (1100 mOsm·kg−1). We quantified the
magnetic susceptibility (|χbead − χm| ≅ χm = 8.400·10−5) and density (ρm = 1.099 g·mL−1) of
this levitation buffer using density standard beads (see Supporting Information).6c We used
two magnets separated by 45 mm in an anti-Helmholtz configuration. In this configuration
the magnetic field strength was 0.38 T at the surface of the magnets; this value provided a
dynamic range in density of 1.056 – 1.143 g·mL−1.
We used a ruler with a millimeter scale to measure the distance from the bottom magnet to a
levitating bead (i.e., the levitation height of the bead). Using a digital camera outfitted with a
macro lens, we could measure this distance with an uncertainty of ±0.1 mm; measuring the
levitation height with the unaided eye increased this uncertainty to ±0.3 mm. In this study,
the greatest source of uncertainty in calculating the density of a bead from the levitation
height of that bead is the measurement of its levitation height. Using a camera, we could,
therefore, measure the change in density of a bead with an uncertainty of ±0.0002 g·cm−3;
without the camera the uncertainty increased to ±0.0006 g·cm−3.
Choice of Model Protein-Ligand System
We defined the basic biophysical chemistry of protein binding using bovine carbonic
anhydrase (BCA) as a model system16 because: (i) BCA is inexpensive and commercially
available. (ii) Numerous inhibitors of BCA are known; many are commercially available,
and have well-characterized binding constants. Many inhibitors of CA contain aryl
sulfonamides, which bind to the active site Zn(II) ion as anionic ligands, and several of the
reported inhibitors can be covalently attached to the polymeric support using standard
coupling chemistry. (iii) BCA is a small protein (~ 30 kDa) and will diffuse in and out of the
PEGA beads (vide supra) used in this study. (iv) BCA has an exceptionally stable tertiary
structure,16 and is not adversely affected by the levitation media. (v) There is extensive
background on the use of carbonic anhydrase in physical organic studies of protein
binding.16 In particular values of Kd, kon, and koff, are known for a number of ligands.
Choice of Solid Support (Resin)
We used commercially available poly[acryloylated O,O′-bis(2-aminopropyl) polyethylene
glycol] (PEGA) beads for this study (300–500 μm diameter in water).17 This resin is
synthesized from 1900 MW PEG. These beads present amine functionality (0.2 mmol·g−1);
this functional group makes chemical modification straightforward. In addition, previous
studies have demonstrated that PEGA beads resist non-specific adsorption of proteins.18–21
This combination of properties has resulted in their widespread use for applications
including: the identification of target proteins of resin-bound small molecules;18 the
screening of libraries of inhibitors;19 the synthesis of peptides;20 and the covalent
immobilization of proteins.21
The density of PEGA beads (ρPEGA ≈ 1.07 g·cm−3) is significantly different from the
density of the protein (ρprotein ≈ 1.3–1.5 g·cm−3).22 This difference in density is required if
binding of protein to the bead is to cause a usefully quantifiable change in the overall
density of the bead.23
The main disadvantage of these commercial PEGA beads is that their small pores (as a
cross-linked acrylamide gel) slow the mass transport of proteins into and through the interior
of the bead, and excludes proteins with molecular weight greater than ~ 40–70 kDa.24 We
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used fluorescein-labeled BCA (FITC-BCA) to estimate both the diffusion coefficient of
BCA in PEGA beads (Dbead ~ 5 × 10−13 m2·s−1) and the partition coefficient of BCA
between the beads and solution (Kbead/sol ~ 0.4, see the supporting information). This value
for the diffusion coefficient of BCA within the bead agrees well with data from the
literature,25 and is approximately two orders of magnitude slower than the diffusion
coefficient in water (~ 9 × 10−11 m2·s−1).26
Unmodified PEGA beads are also difficult to visualize during levitation because their
refractive index is close to that of the solution. To improve the visibility of these beads, we
functionalized a small portion of the amines on them with dyes (e.g., by reaction with the
isothiocyanates of rhodamine, malachite green, and 7-dimethylamino-4-methylcoumarin).
These modifications make the beads easily visible under ambient or UV light.
Model for Quantifying the Amount of Protein Bound Per Bead with MagLev
Using Eqn. 1, we derived Eqn. 2 to correlate changes in the amount of protein bound to the
beads and changes in the levitation height of the bead (Δh, m).
(2)
The change in density, ρbead,p − ρbead, is proportional to the difference in the amount of
protein present in the bead, after displacing an equivalent volume of the buffer solution out
of the bead (Eqn. 3). Here, [P] is the concentration of protein within the bead (M), MWprotein
(g·mol−1) and Vprotein (m3) are the molecular weight and volume of a protein molecule, NA
(mol−1) is the Avogadro constant, and ρsol (kg·m−3) is the density of the solution. Using this
relationship, Δh can be expressed linearly in terms of [P] (Eqn. 4).
(3)
(4)
BCA has a molecular weight of 29.1 kg·mol−1 and a volume of 3 × 10−26 m3 (the protein is
assumed to be a sphere with radius ~ 20 Å).27 Eqn. 4, therefore, predicts that, under our
standard levitation conditions, a 1-mM increase in the concentration of protein within a bead
will result in a 5-mm decrease in levitation height. Experimentally, we obtained a similar
value (Δh/[P] = −8.6 mm/mM, see Supporting Information); the difference between these
experimental and theoretical values is likely due to a discrepancy between the assumed and
actual volume of the protein, Vprotein, and/or to inaccuracies in measurements of the volume
of the beads.
Model for Kinetic Analysis of Binding
MagLev enables the detection of a change in density that occurs when a soluble protein
associates with or dissociates from a ligand that is covalently immobilized on a gel or solid
support (provided that there is a difference in density between the protein and the gel/solid
support). We model the binding of protein to ligands immobilized in a gel matrix by a three-
step process (Figure 2A): (i) partitioning of the protein from solution to the gel (thereby
displacing an equivalent volume of buffer solution from the bead into the bulk solution), (ii)
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diffusion of protein within the gel, (iii) binding and unbinding of protein to the ligands
immobilized in the gel.
Before each experiment, the gel beads are first equilibrated with a buffered solution of
Gd(DTPA). Using a magnetic susceptibility balance, we found that the magnetic
susceptibility of these equilibrated beads is similar to the magnetic susceptibility of the
buffer; this observation indicates that the concentration of Gd(DTPA) in solution is
approximately the same both inside and outside the bead (see Supporting Information). At
the beginning of each experiment (t = 0), the beads are transferred to a solution of protein
dissolved in the same Gd(DTPA) buffer. The process that follows, involving protein
diffusing into the beads and binding to the ligands immobilized there, can be described
mathematically as follows.
Sulfonamide 1, when bound to resin, is expected to bind tightly to BCA (the Kd of an
analogous ligand in solution is 0.7 μM, see Supporting Information). Sulfonamide 2 should
not associate measurably with BCA;16 this functionalized bead serves as a control. The
PEGA beads we used have a density of amine groups of 0.2 mmol·g−1 (when dry); this
value gives a final concentration of ligand within the bead of 1 – 10 mM (when swollen in
water).
The partitioning of the protein between the bead and the solution is described by the
partition coefficient, Kbead/sol (Eqn. 5), where  denotes the concentration of proteins
at the external boundary of the bead and [P]sol denotes the concentration of protein in the
bulk solution. Once inside the bead, the protein, Pbead, diffuses toward the center of the
bead, reacting with the immobilized ligands, *L, to form protein-ligand complexes, *PL,
according to Eqn. 6 (throughout this text, * is used to indicate a species immobilized on the
gel).
(5)
(6)
Together, the dynamics of all these three steps can be expressed mathematically in terms of
a system of reaction-diffusion equations (Eqns. 7, 8).28 In these equations, r is the radial
coordinate of the bead, t is time, and Dbead is the diffusion coefficient of the protein in the
bead.
(7)
(8)
The initial parameters (at t = 0) are defined as follows: (i) The concentration of ligand within
the bead, [*L], is defined as [*L]0. (ii) The concentration of protein in solution ([P]sol) is
equal to [P]0,sol. (iii) There is no protein within the bead ([P]bead = 0). (iv) At the external
boundary of the bead, the concentration of protein is described by the partition coefficient
and the concentration of protein in solution (Eqn. 9).
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(9)
The volume of the bead is assumed to be constant; therefore [*PL] = [*L]0 − [*L].29 Eqn. 10
describes the process of penetration of protein into the bead at its external boundary. In this
equation, A is the surface area of the bead, r is the radial coordinate, Vsol is the volume of
solution and NB is the number of beads used.
(10)
To correspond with our experiments, we used the following parameters for our calculations:
(i) The radius of each bead, R, is 170 μm. (ii) There are 15 beads in each experiment (NB).
(iii) The volume of the solution, Vsol, is 0.6 mL. (iv) The initial concentration of ligand
within the bead, [*L]0 is 3.2 mM. (v) The partition coefficient, Kbead/sol, is 0.4. (vi) The
diffusion coefficient, Dbead, is ~10–12 m2·s−1, as observed in a previous study and
confirmed experimentally by us (see Supporting Information).25 Solving this system of
equations using a finite-difference method30 in spherical coordinates (implemented in
Matlab), gives the concentration profiles of protein, ligand and bound protein-ligand
complex with respect to both space and time. Integrating the concentration profile of bound
protein-ligand throughout the bead gives the total amount of protein-ligand complex in the
bead, nPL (Eqn. 11).31
(11)
Experimentally, we determined that the change in levitation height, Δh (mm), is proportional
to nPL (mmol) and inversely proportional to the volume of the bead, Vbead (L) according to
the relationship Δh = −8.6nPL/Vbead (see Supporting Information; Eqn. 4 provides a
theoretical approximation of this relationship).
The Characteristic Time, τ, of the Reaction-Diffusion Process
We describe here our derivation of a characteristic time parameter, τ, which describes the
time required for the reaction-diffusion process to reach equilibrium; we begin by proving
that this process is diffusion-limited. Eqn. 12 describes the characteristic time for the
binding of protein to ligands within a bead, τrxn. In this expression, kon (M−1s−1) is the
reaction rate constant and [P]bead is a characteristic concentration of protein in the bead; this
concentration can be represented by the product of the partition coefficient, Kbead/sol, and the
initial concentration of protein in the solution, [P]0,sol. Based on the known values of kon (~
105 M−1s−1)16, Kbead/sol (0.4), and [P]0,sol (~100 μM), the characteristic time (τrxn) for the
forward reaction is, therefore, ~ 0.25 s. Eqn. 13 describes the characteristic time for
diffusion of the protein within the bead (τdiff).
(12)
(13)
Given the diffusion coefficient of the protein in the bead, Dbead ~ 10−12 m2·s−1, and a bead
of radius R (~170 μm), we estimate τdiff to be on the order of 8 hours. Since τdiff ≫ τrxn (8 hrs
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≫ 0.25 s), the reaction-diffusion process is diffusion-limited. We, therefore, make the
following two assumptions in order to derive a simple, analytical expression for the
characteristic time of the reaction-diffusion process: (i) the reaction to form the protein-
ligand complex is instantaneous in comparison to the rate of diffusion, and (ii) once formed,
the protein-ligand complex, *PL, does not dissociate (the rate of dissociation is typically
much slower than the rate of association). Given these assumptions, there exists a
propagation front of the protein (Figure 2B), that is a boundary where the concentration of
diffusive protein penetrating into the bead is zero. At the propagation front, the incoming
flux of protein is immediately consumed to form the protein-ligand complex (Eqn. 6)
according to Eqn. 14.
(14a)
(14b)
In this equation, r is the radial coordinate, AF is the cross-sectional area of the front, lF is the
radial position of the front, and dlF/dt is the velocity of the propagating front. We derive an
estimate of the term ∂[P]bead/∂r by considering the region before the propagating front,
where the incoming protein is subject only to diffusion. In this region, we can apply a pseu-
do-steady approximation to the concentration profile of diffusing protein (Eqn. 15).
(15)
This approximation assumes that the concentration profile of diffusing protein is established
much more rapidly than the propagating front moves (this approximation is reasonable when
[P]0,solKbead/sol/[*L]0 ≪ 1, as is the case in our system).32 We derive the average value <1/∂
P]bead/∂r|lF>r across the bead by solving Eqn. 15 using the following boundary conditions:
at r = R, [P]bead = [P]0,solKbead/sol, and at r = lF, [P]bead = 0 (Eqn. 16).
(16)
For the system we describe here, the characteristic time τ of the reaction-diffusion process is
proportional to the radius of the bead R over the average velocity of the propagating front,
dlF/dt (Eqn. 17).32 Finally, combining Eqns. 14, 16, and 17 yields an expression that
describes the characteristic time τ as a function of a number of experimental variables (Eqn.
18).
(17)
(18)
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This expression indicates that the time required for the system to reach steady-state is
proportional to the square of the radius of the beads, R2, the initial concentration of the
ligands in the bead, [*L]0, and is inversely proportional to the diffusion coefficient, Dbead,
the initial concentration of protein in solution, P0,sol and the partition coefficient, Kbead/sol.
These mathematical relationships agree well with experiment (vide supra). In practice, the
characteristic time τ can be derived from a plot of levitation height (h) versus time (t) by
fitting the data to a first-order exponential equation (Eqn. 19), where hf and h0 are the final
and initial levitation heights, respectively.
(19)
RESULTS AND DISCUSSION
This section outlines a detailed physical-organic study of a MagLev-based analytical tool
that can be used for (i) quantifying the amount of protein bound to beads, and (ii) monitoring
the kinetics and thermodynamics of association of proteins with resin-bound small
molecules. We use this physical-organic study to identify the parameters that ultimately
influence the function and practicality of this tool.
Unless specified otherwise, all MagLev measurements were performed in a solution of 300
mM Gd(DTPA), and 0.05% polysorbate 20, dissolved in 6-mM phosphate buffer and
adjusted to pH 7.4 using sodium hydroxide (referred to throughout this text as the “standard
levitation buffer”). This composition provided a buffer with an approximate match in
density to that of the PEGA beads. The chosen concentration of gadolinium(III) provided a
useful compromise between sensitivity and dynamic range of detection by MagLev.
Addition of the non-denaturing surfactant, polysorbate 20, reduced non-specific binding of
proteins to the PEGA beads, and prevented the beads from adhering to the cuvette.
MagLev provides a spectroscopy-free method of measuring the binding of protein to
ligand-functionalized PEGA beads
Initially, we verified that protein would adsorb to PEGA beads only when these beads were
functionalized with a small-molecule ligand that bound specifically to that protein. We
reasoned that the binding of most proteins (average density ≈ 1.3–1.5 g·cm−3) to PEGA
beads (density ≈ 1.07 g·cm−3) should increase the density of the beads, and result in
quantifiable changes in levitation height between bound and unbound states.
Throughout these studies, we used a well-characterized system of proteins and ligands:
bovine carbonic anhydrase (BCA) and derivatives of benzenesulfonamide.16 We
immobilized 4-carboxybenzene sulfonamides 1 and 2 on Rhodamine-dyed PEGA beads
using standard coupling chemistry (Eqn. 20, EDC = N-(3-dimethylaminopropyl)-N′-
ethylcarbodiimide, NHS = N-hydroxysuccinimide, see Supporting Information for more
information).
At least one hour before each experiment, the PEGA beads were placed in a solution of the
standard levitation buffer in order to insure that they equilibrated completely with this
buffer. We then transferred seven to ten beads functionalized with either sulfonamide 1 or 2
into a microcuvette containing 0.6 mL of a solution of BCA in the standard levitation buffer.
We observed only a very small decrease (< 0.1 mm) in the levitation height of beads
functionalized with 4-dimethylsulfamoylbenzoic acid 2 after incubation with 0.33 mM BCA
for 7 days. In contrast, we observed a time- and concentration-dependent change in the
levitation height of beads functionalized with sulfonamide 1.
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(20)
We plotted the change in levitation height of beads functionalized with sulfonamide 1 (Δh,
in millimeters) versus time (t, in hours) for each concentration of BCA and fit these data to
our model of the reaction-diffusion process (Eqns. 7, 8). The comparison demonstrates good
agreement (Figure 3A).33 We estimate the dissociation constant from the model to be Kd ~
1.5 μM. We note that since the process of protein binding to ligands within the beads is
diffusion-limited (see the Section on characteristic time for further discussion), we can only
determine Kd, and not the on and off rates (koff and kon).
Eqn. 21 presents an alternative method of calculating the dissociation constant using the
equilibrium conditions of the reaction summarized in Eqn. 6, and assuming that protein is in
excess.
(21)
Experimentally we found that with [P]0,sol = 100 μM, [*L]0 = 3.2 mM and Kbead/sol = 0.4,
the final change in height of the beads is 26.5 mm; this value indicates that the [*PL]eq is
3.08 mM (Eqn. 4). Substituting these values into Eqn. 21 gives a dissociation constant, Kd,
of 1.5 μM.
These results demonstrate that this MagLev-based method provides reasonable estimates of
binding constants for BCA with benzenesulfonamides, without the need for spectroscopy.
The small difference between the measurements using MagLev and more conventional
spectroscopic methods may be due to an increase in the protein-ligand dissociation constant
as a result of immobilization of the ligand. We previously found that the observed
dissociation constants of BCA with ligands in solution are ~ 10 times lower than the
dissociation constants of the corresponding ligands presented on the surface of a
monolayer.34
The system reaches a state of equilibrium more rapidly when higher concentrations of
protein in solution and/or lower concentrations of ligand within the beads are used
Based on our derivation of the characteristic time, τ, we inferred that both increasing the
concentration of protein in solution, and decreasing the concentration of ligand within the
bead, should increase the rate at which the bead would reach an equilibrium concentration of
protein and protein-ligand complex (τ ~ [L]0/[P]0,sol, Eqn. 18). In addition to decreasing the
assay time, experimenting with these parameters would also allow us to test the validity of
our model. To vary the concentration of ligand within the beads, we combined benzene
sulfonamides 1 and 2 in molar ratios of 1:0, 1:2, 1:8, 1:26, and 1:80. We used these mixtures
to synthesize batches of PEGA beads containing different concentrations (3.2 – 0.040 mM)
of benzene sulfonamide (Eqn. 22).
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(22)
We placed seven to ten of each batch of beads in a microcuvette containing a solution of
100-μM bovine carbonic anhydrase (BCA) dissolved in the standard levitation buffer, and
plotted the change in levitation height (Δh, in millimeters) versus time (t, in hours) for each
concentration of ligand (Figure 3B). Fitting these data to our reaction-diffusion numerical
integration model (Eqns. 3, 10) revealed the expected correlations: lower concentrations of
ligand within the bead resulted in smaller changes in levitation height (Δh = h0 − hf); the
equilibration time was, however, inversely proportional to the concentration of ligand in the
bead.
In order to verify these results further, we repeated the same experiment with several
different concentrations of BCA. Each plot was fit to a first-order exponential curve (Eqn.
19) from which we derived the calculated characteristic times τ. Figure 4 illustrates the
expected mathematical relationships. In Figure 4A, we plot characteristic time against the
concentration of ligand 1 within the bead (τ versus [*1]bead); the data demonstrate the
expected linear relationship, with the exception of the datum at 100% concentration of
sulfonamide 1 and 10-μM protein.35 Similarly, Figure 4B reveals the linear relationship
between the characteristic time and the inverse of the concentration of protein in solution,
(1/[BCA]0,sol; again with exclusion of the datum at 100% concentration of 1 and 10-μM
protein). Thus, equilibration is much faster with lower concentrations of ligand within the
bead ([*L]0), and with higher concentrations of protein in solution ([P]0,sol), as predicted by
both the reaction-diffusion model and our derivation of the characteristic time τ (Eqns. 10,
18).
The rate of equilibration is faster for smaller beads
PEGA beads, as supplied commercially, span a range of sizes. For our studies, beads
purchased from Polymer Laboratories were reported to range in diameter from 300 – 500
microns (when swollen in water). To quantify the effect of bead size on the rate of binding
of protein to ligands within the bead, we isolated the largest and smallest beads by filtering
through several sizes of mesh (see Supporting Information).
We levitated eight large beads (average radius of 166 ± 5 microns) and eight small beads
(average radius of 136 ± 7 microns) in a solution of 130-μM BCA dissolved in the standard
levitation buffer. Figure 5 shows the comparison of the change in levitation height (Δh, in
millimeters) versus time (t, in hours) for each batch of beads. When these data were fit to
first-order exponential curves (Eqn. 19), the calculated characteristic times, τ, were 14.6 ±
2.7 hours for the small beads, and 26.9 ± 2.1 hours for the large beads. This ratio is in accord
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with our prediction of the relationship between the radius of the bead (R) and τ (τ ~ R2, Eqn.
18).
MagLev enables multiple binding interactions to be monitored simultaneously
MagLev provides the basis for an on-bead assay that can measure the affinity of multiple
different resin-bound small molecules for the same protein. To make it possible to
differentiate resin-bound inhibitors visually, we functionalized a small portion of the
available amines on PEGA beads with one of five different dyes (isothiocyanates of
rhodamine, fluorescein, malachite green, eosin and 7-dimethylamino-4-methylcoumarin).
Using standard coupling chemistry, we attached five different ligands (4-carboxybenzene
sulfonamide, 4-(isothiocyanatomethyl) benzenesulfonamide 3-carboxybenzene sulfonamide,
3-carboxy-4-methoxybenzene sulfonamide, and 4-dimethylsulfamoylbenzoic acid) of
carbonic anhydrase to the differently colored beads.
We then suspended these five color-coded beads, each functionalized with a different
inhibitor of BCA, (~15 beads per inhibitor) in a microcuvette containing a solution of 100-
μM BCA dissolved in the standard levitation buffer. Initially, the beads all levitate at nearly
the same height (Figure 6).36 In the presence of BCA, the beads begin to sink, and begin to
segregate based on binding affinities. The relative levitation height of the beads represents
the relative differences in binding affinities of the ligands attached to the beads; the bead
containing the ligand with the lowest dissociation constant for BCA levitates at the lowest
value of h because it has more protein bound to it than the other two beads. Using Eqn. 21,
we calculated the dissociation constants of the immobilized ligands from BCA. We also
measured the dissociation constants of analogous ligands in solution using fluorescence (see
Supporting Information). A comparison of the values measured using both methods
demonstrates good agreement (Figure 6).
At the beginning of the experiment, the beads form relatively tight clusters because they
have equal densities. As the beads approach 50% equilibration, however, they become
increasingly disperse. We hypothesize that this dispersion results from differences in the
percentage of ligands that are bound to protein as a result of differences in the size of the
beads or the size of the pores in the beads.6b As the beads approach their final levitation
height, their dispersion in levitation heights decreases because each bead contains the same
concentration of ligand, and the final equilibrium levitation height ultimately depends only
on the density of the bead, not on its radius.
MagLev is a useful tool for quantifying the concentration of a specific protein
Methods for the detection of small amounts (nmol – fmol) of protein have revolutionized
biotech-nology, and comprise some of the most heavily used methods for the diagnosis of
disease.37 In order to adapt the MagLev-based methods described in this paper to the
detection of small amounts of protein, we utilize a semi-kinetic approach. We begin by
incubating a single bead in a solution of a target protein. To provide optimal detection of
small amounts of protein, we fully functionalize this bead with a ligand that binds tightly to
the target protein. Specifically, we use PEGA beads functionalized with sulfonamide 1 to
detect BCA.
With the goal of detecting low concentrations of protein, it is beneficial to maximize the
sensitivity of the system to changes in the density of the bead by performing measurements
of levitation height using the lowest practical concentration of paramagnetic salt. For these
measurements, we, therefore, utilize a lower concentration of Gd(DTPA) than what is
present in the standard levitation buffer: 150 mM Gd(DTPA) provides a practical
compromise between sensitivity and equilibration time. With this concentration of
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Gd(DTPA), the beads reach their equilibrium levitation height in ~ 30 minutes and we are
able to differentiate between differences in density of ± 0.0004 g·cm−3. With lower
concentrations of Gd(DTPA), sensitivity is increased, but the beads take significantly longer
to reach their equilibrium levitation height.6c Future studies will focus on increasing the rate
of adsorption of protein by using smaller beads, lower concentrations of ligand within the
beads, or beads with larger pore volumes.
Reaching an equilibrium state at low concentrations of protein requires an impractically long
time (for example, a bead functionalized with sulfonamide 1 requires more than one
thousand hours to equilibrate fully with a 10-μM solution of BCA). A calibration curve,
however, can easily be generated to relate the change in levitation height after a given period
of time to the concentration of protein in the sample. Figure 7 demonstrates this
relationship.38
To generate the data in Figure 7A, we incubated individual beads, functionalized with
sulfonamide 1, in solutions (20 μL) of BCA (40 nM – 40 μM) dissolved in 10 mM PBS at
room temperature (20 °C), for either 3 or 24 hours. We then transferred these beads into a
microcuvette containing a solution of 150-mM Gd(DTPA) and 200-mM sucrose dissolved in
6-mM phosphate buffer and adjusted to pH 7.4 with NaOH (referred to hereafter as the ‘high
sensitivity levitation buffer’), and measured their levitation height (in comparison to the
levitation height of a bead that had been incubated in a solution free of BCA). After three
hours, beads that have been incubated in a 600-nM solution of BCA can be distinguished
from beads that have been incubated in a solution free of BCA; after 24 hours the detection
limit is lowered to 300 nM. Notably, this method requires only 20 μL of sample (the volume
of blood in a typical finger prick).
The initial rate of protein absorption correlates linearly with the concentration of protein in
solution (τ ~ 1/[P]0,sol, Eqn. 18); as the ligands become saturated with protein, however, the
rate of net protein diffusion into the beads decreases. The result is that at short incubation
times, there is an approximately linear relationship between the concentration of protein in
the incubation solution and the amount of protein adsorbed on the bead, while at longer
incubation times this simple correlation no longer holds true (at very long incubation times
the system approaches equilibrium, where binding is described by Eqn. 21).
MagLev can be used to detect BCA in blood
This short study was intended to determine if MagLev could operate successfully starting
with samples as complex as blood and serum. We incubated individual beads, functionalized
with sulfonamide 1, in 20 μL aliquots of whole blood containing 2-fold dilutions of BCA
(40 nM – 40 μM). After 3 hours we separated these beads from the blood by filtration
through a fine mesh and rinsed them with levitation buffer. We then transferred the beads
into a microcuvette containing the high sensitivity levitation buffer (described above), and
measured their levitation heights (in comparison to the levitation height of a bead that had
been incubated in whole blood containing no added BCA; Figure 7A). These results indicate
that this method is capable of detecting a specific protein in a complex biological medium
such as blood without the need for initial separation or purification steps.
The temperature of incubation has only a small influence on the reaction-diffusion process
We also examined the temperature dependence of this method of detecting protein (Figure
7B). We incubated PEGA beads, functionalized with sulfonamide 1, in solutions of BCA
(40 nM – 40 μM) at two different temperatures (5 °C, 40 °C) for 24 hours. Only slightly
more protein was absorbed into the beads that were incubated at the warmer temperature.
The difference between the levitation heights of the beads that were incubated at these two
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temperatures is predicted by the inverse relationship between the characteristic time, τ, of
the reaction-diffusion process and the diffusion coefficient of the protein within the bead (τ
~1/Dbead, Eqn. 18). The dependence of the diffusion coefficient, D, on temperature, T, can
be approximated by the Stokes–Einstein equation (Eqn. 23), where kB is Boltzmann’s
constant, η is the dynamic viscosity of the levitation media inside the bead, and R is the
hydrodynamic radius of the protein inside the bead. We assume that the levitation media has
a dynamic viscosity similar to that of water (η5°C = 1.519, η40°C = 0.653), and that R is
independent of temperature; the ratio of Dbead,40°C and Dbead,5°C is, therefore, ~ 2.1. This
value agrees qualitatively with the increased rate of the reaction-diffusion process at higher
temperatures.
(23)
CONCLUSION
MagLev provides a new way to detect and measure specific protein-ligand interactions. Its
simplicity and independence of electricity and infrastructure suggest that, with development,
it has the potential to be useful in resource-limited environments. In this method, the binding
of protein to ligands immobilized within a gel bead results in a change in the density of the
bead. MagLev allows the density of the bead to be monitored in real time with high
accuracy, and therefore provides a direct readout of the amount of protein bound to the bead.
We have developed a mathematical model of the reaction-diffusion processes that result in
the binding of protein to ligands immobilized within the bead. This model provides good
quantitative agreement between theory and experiment. The magnitude of the change in
levitation height as a function of time depends on a number of controllable parameters
including: (i) the concentration of protein in solution, (ii) the structure, concentration, and
binding constant of the ligand immobilized in the bead, and (iii) the size of the bead. The
rate of change in levitation height also depends on a number of factors that are more difficult
to manipulate, such as: (i) the partition coefficient of the protein between the bead and the
bulk solution, and (ii) the diffusion coefficient of protein within the bead. We developed
Eqn. 17, which describes the dependence of the characteristic time, τ, for protein binding to
ligands immobilized within gel beads, on all of the reaction parameters. This equation,
therefore, allows the performance of the system to be predicted, under a variety of
conditions.
Overall, the MagLev-based method for detecting protein-ligand binding has a number of
significant advantages: (i) This method requires no electricity, and only a single piece of
equipment. It may, therefore, find use in situations where portability and low cost are a high
priority; for example, in point-of-care diagnosis, especially in resource-limited, military, and
home environments, or in veterinary medicine, plant pathology, and food safety. (ii) It is
easy to use; results can be visualized with the naked eye. (iii) It has the capability to monitor
binding accurately in real time. This attribute provides a quantitative means of determining
the concentration of a specific protein in solution. (iv) It can qualitatively distinguish the
binding affinities of a protein to several resin-bound small molecules simultaneously. Using
analogous procedures, MagLev should also be capable of measuring the binding of multiple
proteins simultaneously to an array of resin-bound small molecules. This property should
allow for the ready design of multiplexed binding assays. (v) Protein-ligand binding directly
results in a change in levitation height. This method, therefore, does not require intermediate
reagents, such as enzyme-linked secondary antibodies.
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In its present form, this method also has several disadvantages; we summarize them briefly,
but note that there are clear development paths to reduce or eliminate them. These
disadvantages include: (i) The kinetics of protein-ligand binding are relatively slow (on the
order of several days). This problem may potentially be resolved through the design and
synthesis of beads with improved characteristics (e.g., larger pore size). (ii) This method is
only applicable to ligands that are amenable to chemical immobilization on a gel support;
this limitation, however, is inherent to most detection methods that occur on solid support.
(iii) This method is currently not applicable to large proteins, most notably antibodies, due
to the restricted pore size of the PEGA beads we used. (iv) For detection of proteins in blood
or other biological samples, the gel beads must be separated from this sample (e.g. by
filtration) before analysis using Maglev; this process adds time and complexity to the
method.
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Figure 1.
Schematic representation of the device and method based on MagLev for detecting proteins
binding to small molecules immobilized on a diamagnetic bead. The device consists of two
0.4 T NdFeB magnets oriented with like poles facing each other. A diamagnetic bead
suspended in a paramagnetic solution levitates in the presence of the magnetic field when
the gravitational force (Fg) acting on the bead is balanced by the magnetic force (Fm).
Binding of protein to the bead alters its density, and thus its vertical position within the
device.
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Figure 2.
Reaction-diffusion model describing the binding of protein from solution to ligands
immobilized in a gel bead. (A) The model consists of three distinct steps: (i) partitioning of
the protein into the bead, (ii) diffusion within the bead, and (iii) binding of protein to the
ligand immobilized on the bead. (B) In a diffusion-limited process (fast/instantaneous
reaction), reaction only occurs at the propagating front, lF, when the flux of protein (before
the front) encounters the unconsumed ligands at the front. This approximation of the
diffusion-limited process allows us to derive a simplified characteristic time, τ, for the
reaction-diffusion process.
Shapiro et al. Page 19
J Am Chem Soc. Author manuscript; available in PMC 2013 March 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3.
Monitoring the association of bovine carbonic anhydrase (BCA) with 4-carboxybenzene
sulfonamide (1) immobilized on PEGA beads. We levitated functionalized PEGA beads in
cuvettes in the standard levitation buffer. (A) Adding BCA to the levitation media resulted
in a change in levitation height (h) that depended on time, and on the concentration of
protein. The figure shows the fit of the experimental plots to the estimates from the reaction-
diffusion model. The reaction-diffusion model predicts that the time to reach equilibrium
should be proportional to the protein concentration (equilibration is predicted be faster with
higher protein concentrations). (B) We illustrate the effect of the ligand concentration within
the bead on the rate of change in levitation height. The data confirm that the time to reach
equilibrium is inversely proportional to the ligand concentration, as predicted by the
reaction-diffusion model.
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Figure 4.
Effect of the concentration of protein in solution, and the ligand concentration within the
beads, on rates of equilibration. We calculated each characteristic time, τ, by fitting a plot of
levitation height versus time to Eqn. 18. The combined data substantiate our derivation of
the characteristic time (Eqn. 17) by illustrating the predicted linear relationships between
(A) the characteristic time τ and the concentration of ligand within the bead (expressed as
the percentage of the bead functionalized with sulfonamide 1), and (B) the characteristic
time τ and the reciprocal of the concentration of protein in solution (1/[BCA]0,sol).
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Figure 5.
Effect of the radius of the bead on the rate of binding of BCA to ligand-functionalized
beads. We levitated functionalized PEGA beads in cuvettes in the presence of 130 μM BCA
dissolved in the standard levitation buffer. We plot the average levitation height for eight
large beads (<R> = 166 ± 5 μm), and eight small beads (<R> = 136 ± 7 μm) versus time, and
show the predictions of the reaction diffusion model (the dotted and dashed lines).
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Figure 6.
Using MagLev to measure the binding of BCA to several immobilized ligands. This figure
presents a series of photographs showing changes in levitation height over time that result
from incubating PEGA beads functionalized with five different inhibitors of BCA in the
presence of 100-μM BCA dissolved in the standard levitation buffer. We used Eqn. 21 to
calculate the dissociation constants of the immobilized ligands from BCA; also shown, in
parentheses, are the dissociation constants of analogous ligands in solution from BCA (see
Supporting Information).
Shapiro et al. Page 23
J Am Chem Soc. Author manuscript; available in PMC 2013 March 28.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7.
Detecting BCA using MagLev. For these experiments, beads were levitated in the high
sensitivity levitation buffer. (A) We incubated individual beads, functionalized with
sulfonamide 1, in solutions (20 μL) of BCA (40 nM – 40 μM) dissolved in 1 × PBS at room
temperature (20 °C), for either 3 or 24 hours. After incubation, we transferred the beads into
microcuvettes containing the high-sensitivity levitation buffer, and measured their levitation
heights (in comparison to a bead that had been incubated in a solution free of BCA). We
then repeated this experiment, changing the incubation media to whole blood (the beads
were filtered and washed before levitation). The error bars show one standard deviation (n =
7). (B) We examined the temperature dependence of the protein detection process. Over a
24-hour period, beads that were incubated at 5 °C absorbed slightly less protein than beads
that were incubated at 40 °C.
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